Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 306M 213M 186M 171M 159M 302M 20.27B 2.05B 799M 9.95B 798M 781M 34.5B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 306M 213M 186M 171M 159M 302M 20.27B 2.05B 799M 9.95B 798M 781M 34.5B | EV / Sales 2026 * |
109x | EV / Sales 2027 * | 4.2x |
| Free-Float |
86.02% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 10/08/2016 |
Joshua George
DFI | Director of Finance/CFO | - | 08/04/2024 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 22/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 10/08/2016 |
Robert Galyen
BRD | Director/Board Member | - | 01/07/2023 |
Jack Perkowski
CHM | Chairman | 76 | 24/10/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 212M | ||
| -8.45% | -11.77% | +153.56% | +38.09% | 7.22B | ||
| 0.00% | +3.23% | -28.52% | -46.39% | 2.43B | ||
| -3.18% | -5.96% | +70.19% | +174.00% | 1.35B | ||
| +0.33% | +4.36% | +145.84% | +207.21% | 1.13B | ||
| -1.60% | +1.44% | +18.74% | +0.27% | 583M | ||
| +4.41% | +4.59% | -20.65% | -52.03% | 524M | ||
| -1.30% | -0.41% | -11.22% | -3.94% | 307M | ||
| -2.61% | +1.89% | -42.28% | +13.55% | 250M | ||
| -1.84% | -2.44% | -31.33% | -52.24% | 208M | ||
| Average | -0.04% | -3.25% | +28.26% | +30.95% | 1.56B | |
| Weighted average by Cap. | -4.37% | -9.54% | +91.32% | +42.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.94M 1.7M 1.57M 1.45M 2.76M 185M 18.76M 7.3M 90.97M 7.3M 7.14M 315M | 73M 50.66M 44.36M 40.86M 37.93M 72.03M 4.83B 489M 190M 2.37B 190M 186M 8.22B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















